Literature DB >> 11931711

Immunomodulatory activity of orphanin FQ/nociceptin on traumatic rats.

Hui Zhao1, Gen-Cheng Wu, Xiao-Ding Cao.   

Abstract

AIM: To explore the neuro-immune modulatory effect of orphanin FQ/nociceptin (OFQ) and opioid receptor like 1 (ORL1) receptor on the traumatic rats.
METHODS: The quantitative method of immuno-cytochemistry and i n situ hybridization combined with cytokine bioassay were used to detect the expression of endogenous OFQ and ORL1 and the production of interleukin-1 (IL-1) and tumor necrosis factor-alpha (TNF-alpha) from peritoneal macrophage.
RESULTS: Strong signals for both OFQ immuno-reactive cells and ORL1 mRNA were detected in cerebral cortex, hippocampus, and hypothalamus in normal condition, whereas they were significantly reduced after trauma (P<0.05). However, the production of IL-1 and TNF-alpha from peritoneal macrophage was increased, when expressed as percentage of enhancement, the increment attained to 233 % and 521 % (sample dilution 1:4), 195 % and 566 % (1:8), 233 % and 757 % ( 1:16), 214 % and 622 % (1:32), respectively, after trauma. After icv injection of OFQ at doses of 0.055 nmol, 0.55 nmol, and 2.75 nmol, the units of IL-1 and TNF-alpha were reversed (P<0.05); however, the action of OFQ (0.55 nmol) was blocked by ORL1 selective antagonist [phe1psi(CH2-NH)Gly2]nociceptin-(1-13)-NH2.
CONCLUSION: OFQ and ORL1, the new opioid peptide system, are involved in the immune response elicited by traumatic stress.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11931711

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  6 in total

Review 1.  Opioid and nociceptin receptors regulate cytokine and cytokine receptor expression.

Authors:  M J Finley; C M Happel; D E Kaminsky; T J Rogers
Journal:  Cell Immunol       Date:  2008-02-14       Impact factor: 4.868

Review 2.  Nociceptin system as a target in sepsis?

Authors:  Róisín Thomas; Cordula Stover; David G Lambert; Jonathan P Thompson
Journal:  J Anesth       Date:  2014-04-12       Impact factor: 2.078

3.  Suppression of CCL2/MCP-1 and CCL5/RANTES expression by nociceptin in human monocytes.

Authors:  David E Kaminsky; Thomas J Rogers
Journal:  J Neuroimmune Pharmacol       Date:  2007-09-15       Impact factor: 4.147

4.  NOP Receptor Ligands as Potential Agents for Inflammatory and Autoimmune Diseases.

Authors:  Elaine C Gavioli; Pedro R T Romão
Journal:  J Amino Acids       Date:  2011-11-17

5.  Minocycline enhances the effectiveness of nociceptin/orphanin FQ during neuropathic pain.

Authors:  Katarzyna Popiolek-Barczyk; Ewelina Rojewska; Agnieszka M Jurga; Wioletta Makuch; Ferenz Zador; Anna Borsodi; Anna Piotrowska; Barbara Przewlocka; Joanna Mika
Journal:  Biomed Res Int       Date:  2014-09-03       Impact factor: 3.411

6.  Endogenous nociceptin / orphanin FQ system involvement in hypothalamic-pituitary-adrenal axis responses: relevance to models of inflammation.

Authors:  J D Leggett; K L Dawe; D S Jessop; A J Fulford
Journal:  J Neuroendocrinol       Date:  2009-09-01       Impact factor: 3.627

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.